Summary.-Antibody was detected by membrane immunofluorescence tests in sera of rats bearing an ascitic variant of a transplanted hepatoma, and in concentrated cell-free ascitic fluid. Ascites hepatoma cells were also shown to have immunoglobulin, possibly tumour specific antibody, bound to their surface. The kinetics of antibody responses to ascites hepatoma and hepatoma cells from solid tumours were compared: both tumour types gave positive reactions by the third day after implantation; antibody was present throughout subsequent tumour growth with the ascites whereas antibody was not detected after tumour became palpable in rats injected with hepatoma cells from solid tumour. Antibody responses to ascites tumour were investigated in rats bearing solid hepatoma tumour. Subcutaneous hepatoma did not influence the antibody response to ascites, but rats bearing intraperitoneal tumours showed a diminished serum antibody response to ascitic hepatoma.
Summary.-Antibody was detected by membrane immunofluorescence tests in sera of rats bearing an ascitic variant of a transplanted hepatoma, and in concentrated cell-free ascitic fluid. Ascites hepatoma cells were also shown to have immunoglobulin, possibly tumour specific antibody, bound to their surface. The kinetics of antibody responses to ascites hepatoma and hepatoma cells from solid tumours were compared: both tumour types gave positive reactions by the third day after implantation; antibody was present throughout subsequent tumour growth with the ascites whereas antibody was not detected after tumour became palpable in rats injected with hepatoma cells from solid tumour. Antibody responses to ascites tumour were investigated in rats bearing solid hepatoma tumour. Subcutaneous hepatoma did not influence the antibody response to ascites, but rats bearing intraperitoneal tumours showed a diminished serum antibody response to ascitic hepatoma.
AsCITIC variants of animal tumours are widely used in experimental cancer research; carriage of tumours as transplanted lines is simple with this form of growth, which also provides a convenient source of monodisperse cells. However, there are few studies of the distinctive immunological properties of ascitic variants derived from solid tumours, especially in syngeneic systems. The present paper describes serum antibody responses detectable by membrane immunofluorescence to an ascitic hepatoma transplanted in syngeneic rats.
The immunology of azo dye induced hepatomata transplanted as solid tumours has been studied extensively in this laboratory. A notable feature of these tumours is an individual antigenicity, which was detected initially by transplantation techniques (Baldwin and Barker, 1967a) . Sera from hepatoma immune rats were subsequently shown to contain antibody detectable by membrane immunofluorescence on viable hepatoma cells and these reactions were also shown to be specific for the immunizing hepatoma (Baldwin and Barker, 1967b) . Tumour specific cytotoxicity against cultured hepatoma cells has been demonstrated using serum or lymph node cells from hepatoma immune rats (Baldwin and Embleton, 1971) . More recently, tumour specific immune responses have been investigated in rats bearing progressively growing hepatoma (Baldwin, Embleton and Robins, 1973b; Baldwin, Price and Robins, 1973c) , including definition of serum factors blocking cellular cytotoxicity Robins, 1972, 1973d; Robins and Baldwin, 1974) .
The following study illustrates some of the features of the antibody response to an ascitic variant of hepatoma D23 and the interaction of that response with the growth of the same hepatoma as a solid tumour.
MATERIALS AND METHODS
Rats and tamours.-The syngeneic strain of Wistar rats and hepatomata induced by 4-dimethylaminoazobenzene used in these studies have been described previously (Baldwin, Embleton and Robins, 1973a Fig. 1 The interaction of the antibody response to D23As with the growth of D23 as a solid tumour is illustrated in Fig. 3 . Solid tumours were produced by intraperitoneal injection of tumour mince (D23 i.p.), or subcutaneous implantation of a tumour graft (D23 s.c.). Antibodies were not detected in sera of rats inoculated with solid tumour alone. Groups of rats were injected with l 07 D23As cells 6 days after administration of solid tumour and in the case of D23 i.p. tumour bearing rats the average fluorescence index was below 0 3 although some sera gave positive reactions. In contrast, sera from rats injected with D23As 6 days after D23 s.c. gave positive fluorescence indices very similar to those from rats injected with D23As alone.
DISCUSSION
The experiments reported in this paper show that rats bearing a syngeneic ascitic hepatoma (D23As) develop a strong antibody response to the tumour specific antigen of this hepatoma. Thus, free antibody detectable by membrane immunofluorescence was present in the serum from the third day after implantation of viable hepatoma cells and sera gave positive reactions throughout subsequent tumour growth. Also, ascites hepatoma cells were shown to have immunoglobulin at their surface, and absorption experiments indicate that this immunoglobulin may be specific antibody bound to cell surface tumour antigen.
There are few previous reports concerning specific antibody production in response to ascitic variants of solid tumours. Thunold (1968) Recent studies of serum antibody and antigen during the growth of hepatoma D23 as solid subcutaneous and intraperitoneal tumours are relevant to these facts. With subcutaneous tumours, free antigen was present in the early stages of growth (7-10 days after tumour implantation). This was followed by a phase when immune complexes were present, and finally, free antibody was detected in the terminal stages of tumour growth (Bowen, Robins and Baldwin, 1974) . With intraperitoneal hepatoma, serum is in antigen excess throughout tumour growth (Baldwin, Bowen and Price, 1973a) . Thus the rate of antigen release by solid tumour is dependent on the site of growth, and this in turn could influence the serum antibody level during the simultaneous growth of ascites and solid tumours.
These considerations emphasize the complexity of the interaction between tumour growth, the host response and serum factors present at a given stage of tumour development. Model systems such as the syngeneic rat hepatoma should allow elucidation of these interactions and their possible influence on tumour growth. This work was supported by a scholarship from the Medical Research Council and a grant from the Cancer Research Campaign to Professor R. W. Baldwin. The advice and encouragement of Professor Baldwin is also gratefully acknowledged.
